Ethical Compliance
MARKSANS PHARMA
Sector:
Healthcare
Industry:
Drug Manufacturers - General
Market Cap Class:
medium
Revenue
1.7%
Debt
1.1%
Liquidity
25.1%
Revenue
Debt
Liquidity
1.7%
Non Compliant
Questionable
Compliant
Compliant
INR Crores
| Pharmaceuticals Products | ₹2,174.32 |
| Other Operating Income | ₹3.21 |
| Other Income | ₹12.27 |
Questionable
INR Crores
| Investment Gain | ₹4.36 |
Non Compliant
INR Crores
| Interest Income | ₹33.79 |
INR Crores
| Revenue from Questionable Sources: | ₹4.36 |
| Revenue from Non Compliant Sources: | ₹33.79 |
| Total: | ₹38.15 |
| Total Revenue: | ₹2,227.83 |
Formula
Revenue from Questionable & Non Compliant Sources
Total Revenue
≤ 0.03 or 3%
Calculation
₹38.15
₹2,227.83
= 1.7%
compliant
Rationale
The sum of revenue from questionable and non-compliant sources should not exceed 3% of the total revenue. This ensures that the company has tolerable reliance on unethical sources of revenue.